Literature DB >> 31288067

Transcription factors in SOX family: Potent regulators for cancer initiation and development in the human body.

Prasann Kumar1, Tapan Kumar Mistri2.   

Abstract

Transcription factors (TFs) have a key role in controlling the gene regulatory network that sustains explicit cell states in humans. However, an uncontrolled regulation of these genes potentially results in a wide range of diseases, including cancer. Genes of the SOX family are indeed crucial as deregulation of SOX family TFs can potentially lead to changes in cell fate as well as irregular cell growth. SOX TFs are a conserved group of transcriptional regulators that mediate DNA binding through a highly conserved high-mobility group (HMG) domain. Accumulating evidence demonstrates that cell fate and differentiation in major developmental processes are controlled by SOX TFs. Besides; numerous reports indicate that both up- and down-regulation of SOX TFs may induce cancer progression. In this review, we discuss the involvement of key TFs of SOX family in human cancers.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Drug; SOX factors; Signalling; Tumour

Year:  2019        PMID: 31288067     DOI: 10.1016/j.semcancer.2019.06.016

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  11 in total

1.  SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation.

Authors:  Xiaosong Hu; Ruochen Liu; Jianbing Hou; Wen Peng; Sicheng Wan; Minghao Xu; Yongsen Li; Guanghui Zhang; Xuan Zhai; Ping Liang; Hongjuan Cui
Journal:  Oncogene       Date:  2022-08-17       Impact factor: 8.756

2.  UCHL3 promotes proliferation of colorectal cancer cells by regulating SOX12 via AKT/mTOR signaling pathway.

Authors:  Jiangning Li; Yang Zheng; Xiaofeng Li; Xue Dong; Weiyan Chen; Zhongying Guan; Chong Zhang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  Serum proteome profiling reveals SOX3 as a candidate prognostic marker for gastric cancer.

Authors:  Jiajia Shen; Jing Zhai; Xinqian Wu; Guiping Xie; Lizong Shen
Journal:  J Cell Mol Med       Date:  2020-05-04       Impact factor: 5.310

4.  Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis.

Authors:  Chunhong Hong; Shaohua Yang; Qiaojin Wang; Shiqiang Zhang; Wenhui Wu; Jinyao Chen; Danhui Zhong; Mingzhe Li; Liang Li; Jianfeng Li; Hong Yu; Hong Chen; Qianlin Zeng; Changhua Zhang
Journal:  Front Genet       Date:  2021-03-18       Impact factor: 4.599

5.  Scrapie-Responsive Gene 1 Promotes Chondrogenic Differentiation of Umbilical Cord Mesenchymal Stem Cells via Wnt5a.

Authors:  Yuchuan Zhou; Tian Zheng; Lin Li; Yangfang Guo; Jiayu Xiao; Jin Wang; Zhiqin Du; Hui Gao; Weiwei Tang; Liusan Yang; Haiyan Hu; Xiaodan Wang; Mingyao Meng; Zongliu Hou
Journal:  Stem Cells Int       Date:  2022-01-27       Impact factor: 5.443

Review 6.  Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives.

Authors:  Ali Dehshahri; Alessio Biagioni; Hadi Bayat; E Hui Clarissa Lee; Mohammad Hashemabadi; Hojjat Samareh Fekri; Ali Zarrabi; Reza Mohammadinejad; Alan Prem Kumar
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

Review 7.  Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy.

Authors:  Xiangyuan Luo; Xiaoyu Ji; Meng Xie; Tongyue Zhang; Yijun Wang; Mengyu Sun; Wenjie Huang; Limin Xia
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

8.  Connection between SOX7 Expression and Breast Cancer Prognosis.

Authors:  Chun-Xin Qin; Xiao-Qing Yang; Zhi-Yong Zhan
Journal:  Med Sci Monit       Date:  2020-04-02

9.  Down-regulation of exosomal miR-200c derived from keratinocytes in vitiligo lesions suppresses melanogenesis.

Authors:  Chaoshuai Zhao; Dongliang Wang; Xin Wang; Yaqi Mao; Ziqian Xu; Yue Sun; Xingyu Mei; Jun Song; Weimin Shi
Journal:  J Cell Mol Med       Date:  2020-09-11       Impact factor: 5.310

10.  CRISPR/Cas9 Deletion of SOX2 Regulatory Region 2 (SRR2) Decreases SOX2 Malignant Activity in Glioblastoma.

Authors:  Ander Saenz-Antoñanzas; Veronica Moncho-Amor; Jaione Auzmendi-Iriarte; Alejandro Elua-Pinin; Karine Rizzoti; Robin Lovell-Badge; Ander Matheu
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.